ADMA Biologics Inc (ADMA) Financials
ADMA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 329.2 million | 194.0 million |
2023-09-30 | 349.0 million | 197.6 million |
2023-06-30 | 343.0 million | 196.3 million |
2023-03-31 | 340.8 million | 195.1 million |
ADMA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 16.2 million | 1.7 million |
2023-09-30 | 11.2 million | 1.7 million |
2023-06-30 | -6.9 million | 1.6 million |
2023-03-31 | -16.7 million | 1.1 million |
ADMA Net Income
No data available :(
ADMA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 51.4 million | - | 10.8 million |
2023-09-30 | 74.2 million | - | 10.9 million |
2023-06-30 | 62.5 million | - | 11.2 million |
2023-03-31 | 69.2 million | - | 11.4 million |
ADMA Shares Outstanding
ADMA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.4 million | 445486 | 15.5 million | - |
2023-09-30 | 756557 | 595903 | 14.7 million | - |
2023-06-30 | 872633 | 1.4 million | 15.6 million | - |
2023-03-31 | 1.9 million | 855351 | 16.3 million | - |
ADMA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 73.9 million | 43.0 million |
2023-09-30 | 67.3 million | 42.6 million |
2023-06-30 | 60.1 million | 43.4 million |
2023-03-31 | 56.9 million | 40.4 million |
ADMA
Price: $6.92
52 week price:
Earnings Per Share: -0.13 USD
P/E Ratio: -48.11
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.7 million
Ebitda: -13.6 millionMarket Capitalization: 1.4 billion